Skip to main content

An open letter to the Food and Drug Administration regarding the use of morcellation procedures in women having surgery for presumed uterine myomas.

Parker W, Berek JS, Pritts E, & et al.
J Minim Invasive Gynecol. pii: S1553-4650(15)01732-X. doi: 10.1016/j.jmig.2015.12.012. [Epub ahead of print]
2016-01-08

Abstract

An open letter to the Food and Drug Administration regarding the use of morcellation procedures in women having surgery for presumed uterine myomas.

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?